Multiple myeloma: past, present and future--editorial

Xiao Yan Ke, Yan Fang Wang, Yu Hua Yang, Lu Hua Wang

Research output: Contribution to journalEditorialpeer-review

Abstract

Multiple myeloma is a neoplasm of mature and immature plasma cells, it remains an incurable disease using conventional chemotherapy and increasing aggressive approaches. In recent years, due to the better understanding of myeloma biology, genetics and tumor formation, there are lots of new active drugs or combinational chemotherapy regimens having been developed, such as proteasome inhibitors, immunomodulatory agents etc, they are more effective than conventional chemotherapy. This article summarizes the recent advances with the new options for the treatment of multiple myeloma.

Original languageEnglish (US)
Pages (from-to)231-239
Number of pages9
JournalZhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology
Volume16
Issue number2
StatePublished - Apr 2008

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Multiple myeloma: past, present and future--editorial'. Together they form a unique fingerprint.

Cite this